Clinical interventions for adults with comorbid alcohol use and depressive disorders: A systematic review and network meta-analysis
Open accessThe DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Abstract
Background: Uncertainty remains regarding the effectiveness of treatments for patients diagnosed with both an alcohol use disorder (AUD) and depressive disorder. This study aimed to compare the effectiveness of clinical interventions for improving symptoms of adults with co-occurring AUDs and depressive disorders. Methods and findings: We searched CINAHL, ClinicalTrials.gov, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, Excerpta Medica Database, International Clinical Trials Registry Platform (ICTRP), PubMed, PsycINFO, and Web of Science from inception to December 2020. We included randomized controlled trials (RCTs) evaluating clinical interventions for adults with co-occurring AUDs and depressive disorders. Two independent reviewers extracted study-level information and outcome data. We assessed risk of bias using the Cochrane Risk of Bias tool, used frequentist random effects models for network meta-analyses, and rated our confidence in effect estimates using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. Primary outcomes were remission from depression and alcohol use. Secondary outcomes were depressive symptoms, alcohol use, heavy drinking, health-related quality of life, functional status, and adverse events. We used standardized mean differences (SMDs) for continuous outcomes and odds ratios (ORs) for dichotomous outcomes to estimate intervention effects. Overall, 36 RCTs with 2,729 participants evaluated 14 pharmacological and 4 psychological interventions adjunctive to treatment as usual (TAU). Studies were published from 1971 to 2019, conducted in 13 countries, and had a median sample size of 50 participants (range: 14 to 350 participants). We have very low confidence in all estimates of intervention effects on our primary outcomes (i.e., remission from depression and remission from alcohol use). We have moderate confidence that cognitive behavioral therapies (CBTs) demonstrated greater benefit than no additional treatment (SMD = −0.84; 95% confidence interval [CI], −1.05 to −0.63; p < 0.001) for depressive symptoms and low confidence (SMD = −0.25; 95% CI, −0.47 to −0.04; p = 0.021) for alcohol use. We have low confidence that tricyclic antidepressants (TCAs) demonstrated greater benefit than placebo (SMD = −0.37; 95% CI, −0.72 to −0.02, p = 0.038) for depressive symptoms. Compared with placebo, we have moderate confidence that selective serotonin reuptake inhibitors (SSRIs) demonstrated greater benefit for functional status (SMD = −0.92; 95% CI, −1.36 to −0.47, p < 0.001) and low confidence for alcohol use (SMD = −0.30; 95% CI, −0.59 to −0.02, p = 0.039). However, we have moderate confidence that patients receiving SSRIs also were more likely to experience an adverse event (OR = 2.20; 95% CI, 0.94 to 5.16, p = 0.07). We have very low confidence in all other effect estimates, and we did not have high confidence in any effect estimates. Limitations include the sparsity of evidence on intervention effects over the long term, risks of attrition bias, and heterogeneous definitions of adverse events in the evidence base. Conclusions: We are very uncertain about the existence (or not) of any non-null effects for our primary outcomes of remission from depression and remission from alcohol use. The available evidence does suggest that CBTs likely reduced, and TCAs may have resulted in a slight reduction of depressive symptoms. SSRIs likely increased functional status, and SSRIs and CBTs may have resulted in a slight reduction of alcohol use. However, patients receiving SSRIs also likely had an increased risk of experiencing an adverse event. In addition, these conclusions only apply to postintervention and are not against active comparators, limiting the understanding of the efficacy of interventions in the long term as well as the comparative effectiveness of active treatments. As we did not have high confidence in any outcomes, additional studies are warranted to provide more conclusive evidence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“some research suggests that combining SSRIs with AUD treatment can yield significant benefits”
From Navigating the Complex Intersection of Substance Use and Psychiatric Disorders: A Comprehensive Review (2024) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
(1992) · PubMed · Cited by 33,716
PRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223 · cited 3×
“We prepared the protocol and this report using the relevant Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P) 2015 Statement [15,16], as well as the Methodological Expectations of Cochrane Intervention Reviews [17].”
MethodDermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Damschroder, L. J., Aron, D. C., Keith, R. E., Kirsh, S. R., Alexander, J. A., & Lowery, J. C. (2009) · Implementation Science · doi:10.1186/1748-5908-4-50 · Cited by 14,496 · cited 2×
“We collected participant data based on the PRISMA-Equity Extension [25,26], intervention and comparator data using the template for intervention description and replication [27], outcome data using ClinicalTrials.gov criteria for completed defined outcomes [28], study setting data using the Consolidated Framework for…”
MethodA new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
Shamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., Stewart, L. A., & the PRISMA-P Group (2015) · BMJ · doi:10.1136/bmj.g7647 · Cited by 13,120
Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation
Beck, A. T., Steer, R. A., & Carbin, M. G. (1988) · Clinical Psychology Review · doi:10.1016/0272-7358(88)90050-5 · Cited by 11,696
Hoffmann, T. C., Glasziou, P. P., Boutron, I., Milne, R., Perera, R., Moher, D., Altman, D. G., Barbour, V., Macdonald, H., Johnston, M., et al. (2014) · BMJ · doi:10.1136/bmj.g1687 · Cited by 10,548 · cited 1×
“Data extraction We collected participant data based on the PRISMA-Equity Extension [25,26], intervention and comparator data using the template for intervention description and replication [27], outcome data using ClinicalTrials.”
Method(1976) · Medical Entomology and Zoology · Cited by 8,899
Hutton, B., Salanti, G., Caldwell, D. M., Chaimani, A., Schmid, C. H., Cameron, C., Ioannidis, J. P. A., Straus, S., Thorlund, K., Jansen, J. P., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2385 · Cited by 8,269 · cited 2×
“(XLSX) S1 PRISMA Checklist.”
MethodSPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
Chan, A.-W., Tetzlaff, J. M., Gotzsche, P. C., Altman, D. G., Mann, H., Berlin, J. A., Dickersin, K., Hrobjartsson, A., Schulz, K. F., Parulekar, W. R., et al. (2013) · BMJ · doi:10.1136/bmj.e7586 · Cited by 6,251
The Global Assessment Scale: A Procedure for Measuring Overall Severity of Psychiatric Disturbance
Endicott, J. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770060086012 · Cited by 4,982
The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory
Derogatis, L. R., Lipman, R. S., Rickels, K., Uhlenhuth, E. H., & Covi, L. (1974) · Behavioral Science · doi:10.1002/bs.3830190102 · Cited by 4,604
The fifth edition of the addiction severity index
McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., Pettinati, H., & Argeriou, M. (1992) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(92)90062-s · Cited by 4,222
Salanti, G., Ades, A. E., & Ioannidis, J. P. A. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.03.016 · Cited by 3,766 · cited 1×
“For each outcome and time point, we ranked interventions in order of effectiveness using p scores—a frequentist measure of the extent of certainty that an intervention is better than another intervention averaged over all competing interventions [41,42].”
MethodThe Michigan Alcoholism Screening Test: The Quest for a New Diagnostic Instrument
SELZER, M. L. (1971) · American Journal of Psychiatry · doi:10.1176/ajp.127.12.1653 · Cited by 3,438
The clinical global impressions scale: applying a research tool in clinical practice.
Busner, J., & Targum, S. D. (2007) · PubMed · Cited by 2,759
Grant, B. F., Goldstein, R. B., Saha, T. D., Chou, S. P., Jung, J., Zhang, H., Pickering, R. P., Ruan, W. J., Smith, S. M., Huang, B., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0584 · Cited by 2,556 · cited 27×
“Studies had to include adult participants (at least 50% were 18 years of age or older) with clinical diagnoses for both an AUD and depressive disorder according to Diagnostic and Statistical Manual of Mental Disorders (DSM) or International Classification of Diseases (ICD) criteria.”
BackgroundInfluentialChecking consistency in mixed treatment comparison meta-analysis
Dias, S., Welton, N. J., Caldwell, D. M., & Ades, A. E. (2010) · Statistics in Medicine · doi:10.1002/sim.3767 · Cited by 2,521 · cited 1×
“We assessed between-study clinical and methodological heterogeneity by examining study characteristics, between-study statistical heterogeneity for each pairwise comparison using the I(2) statistic, local inconsistency by splitting and comparing direct and indirect evidence [38], and global inconsistency using designb…”
MethodGRADE guidelines: 7. Rating the quality of evidence—inconsistency
Guyatt, G. H., Oxman, A. D., Kunz, R., Woodcock, J., Brozek, J., Helfand, M., Alonso-Coello, P., Glasziou, P., Jaeschke, R., Akl, E. A., et al. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.03.017 · Cited by 2,320
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000251 · Cited by 2,296
How Big is a Big Odds Ratio? Interpreting the Magnitudes of Odds Ratios in Epidemiological Studies
Chen, H., Cohen, P., & Chen, S. (2010) · Communications in Statistics - Simulation and Computation · doi:10.1080/03610911003650383 · Cited by 1,952
(1993) · PubMed · Cited by 1,900
The PRECIS-2 tool: designing trials that are fit for purpose
Loudon, K., Treweek, S., Sullivan, F., Donnan, P., Thorpe, K. E., & Zwarenstein, M. (2015) · BMJ · doi:10.1136/bmj.h2147 · Cited by 1,846 · cited 1×
“To ensure their utility in overcoming limitations of the current body of evidence for informing policy and practice, researchers should design future studies that are adequately powered and fit for this pragmatic purpose [53], prospectively register fully developed protocols and statistical analysis plans [54,55], and…”
BackgroundGRADE guidelines: 8. Rating the quality of evidence—indirectness
Guyatt, G. H., Oxman, A. D., Kunz, R., Woodcock, J., Brozek, J., Helfand, M., Alonso-Coello, P., Falck-Ytter, Y., Jaeschke, R., Vist, G., et al. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.04.014 · Cited by 1,843
Puhan, M. A., Schunemann, H. J., Murad, M. H., Li, T., Brignardello-Petersen, R., Singh, J. A., Kessels, A. G., Guyatt, G. H., & for the GRADE Working Group (2014) · BMJ · doi:10.1136/bmj.g5630 · Cited by 1,812
Ranking treatments in frequentist network meta-analysis works without resampling methods
Rücker, G., & Schwarzer, G. (2015) · BMC Medical Research Methodology · doi:10.1186/s12874-015-0060-8 · Cited by 1,732 · cited 1×
“For each outcome and time point, we ranked interventions in order of effectiveness using p scores—a frequentist measure of the extent of certainty that an intervention is better than another intervention averaged over all competing interventions [41,42].”
MethodSalanti, G. (2012) · Research Synthesis Methods · doi:10.1002/jrsm.1037 · Cited by 1,729 · cited 2×
“We then qualitatively examined the distribution of characteristics across studies in each network that may modify intervention effects to assess the transitivity assumption of NMA—that is, that participants hypothetically could be randomized to any interventions included in a network [32,33].”
BackgroundMethodEvaluating the quality of evidence from a network meta-analysis
Salanti, G., Del Giovane, C., Chaimani, A., Caldwell, D. M., & Higgins, J. P. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099682 · Cited by 1,402
Network meta‐analysis for indirect treatment comparisons
Lumley, T. (2002) · Statistics in Medicine · doi:10.1002/sim.1201 · Cited by 1,206
Santesso, N., Glenton, C., Dahm, P., Garner, P., Akl, E. A., Alper, B., Brignardello-Petersen, R., Carrasco-Labra, A., De Beer, H., Hultcrantz, M., et al. (2020) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.10.014 · Cited by 1,198 · cited 1×
“Based on these assessments, we reported our confidence in each pairwise effect estimate using 1 of 4 categories [47,48].”
MethodPsychotherapy for depression in adults: A meta-analysis of comparative outcome studies.
Cuijpers, P., van Straten, A., Andersson, G., & van Oppen, P. (2008) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0013075 · Cited by 1,050
(2016) · Cochrane Database of Systematic Reviews · Cited by 985
Global Assessment of Functioning
Hall, R. C. W. (1995) · Psychosomatics · doi:10.1016/s0033-3182(95)71666-8 · Cited by 975
Jonas, D. E., Amick, H. R., Feltner, C., Bobashev, G., Thomas, K., Wines, R., Kim, M. M., Shanahan, E., Gass, C. E., Rowe, C. J., et al. (2014) · JAMA · doi:10.1001/jama.2014.3628 · Cited by 923 · cited 25×
“Studies had to include adult participants (at least 50% were 18 years of age or older) with clinical diagnoses for both an AUD and depressive disorder according to Diagnostic and Statistical Manual of Mental Disorders (DSM) or International Classification of Diseases (ICD) criteria.”
BackgroundInfluentialThe GRADE Working Group clarifies the construct of certainty of evidence
Hultcrantz, M., Rind, D., Akl, E. A., Treweek, S., Mustafa, R. A., Iorio, A., Alper, B. S., Meerpohl, J. J., Murad, M. H., Ansari, M. T., et al. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.05.006 · Cited by 853 · cited 1×
“Based on these assessments, we reported our confidence in each pairwise effect estimate using 1 of 4 categories [47,48].”
MethodThe ClinicalTrials.gov Results Database — Update and Key Issues
Zarin, D. A., Tse, T., Williams, R. J., Califf, R. M., & Ide, N. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmsa1012065 · Cited by 838 · cited 1×
“gov criteria for completed defined outcomes [28], study setting data using the Consolidated Framework for Implementation Research [29], and study design data using the revised Cochrane tool [30].”
MethodDeveloping core outcome measurement sets for clinical trials: OMERACT filter 2.0
Boers, M., Kirwan, J. R., Wells, G., Beaton, D., Gossec, L., d'Agostino, M.-A., Conaghan, P. G., Bingham, C. O., Brooks, P., Landewé, R., et al. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.11.013 · Cited by 781 · cited 1×
“While most data come from established measures for depressive symptoms, drinking, withdrawal and craving symptoms, quality of life, and functional status, the development and use of core outcome measurement sets for this clinical area would help allay concerns about the sensitivity of the direction and magnitude-of-ef…”
BackgroundAdvances in the GRADE approach to rate the certainty in estimates from a network meta-analysis
Brignardello-Petersen, R., Bonner, A., Alexander, P. E., Siemieniuk, R. A., Furukawa, T. A., Rochwerg, B., Hazlewood, G. S., Alhazzani, W., Mustafa, R. A., Murad, M. H., et al. (2018) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.10.005 · Cited by 753 · cited 2×
“Due to significant inconsistency between designs, we used meta-analytic estimates derived from only direct evidence (rather than network meta-analytic estimates based in part on indirect evidence) for psychological interventions with direct comparisons [43,45].”
MethodNetwork meta‐analysis, electrical networks and graph theory
Rücker, G. (2012) · Research Synthesis Methods · doi:10.1002/jrsm.1058 · Cited by 730 · cited 1×
“We addressed within-study correlation of effects from multiarm trials through the netmeta procedures for reweighting all comparisons of each multiarm trial [35,36].”
MethodWelch, V., Petticrew, M., Tugwell, P., Moher, D., O'Neill, J., Waters, E., White, H., & the PRISMA-Equity Bellagio group (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001333 · Cited by 704 · cited 2×
“We collected participant data based on the PRISMA-Equity Extension [25,26], intervention and comparator data using the template for intervention description and replication [27], outcome data using ClinicalTrials.gov criteria for completed defined outcomes [28], study setting data using the Consolidated Framework for…”
MethodAnton, R. F., Moak, D. H., & Latham, P. (1995) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1995.tb01475.x · Cited by 677
Quantifying the impact of between-study heterogeneity in multivariate meta-analyses
Jackson, D., White, I. R., & Riley, R. D. (2012) · Statistics in Medicine · doi:10.1002/sim.5453 · Cited by 577 · cited 1×
“We assumed a constant heterogeneity variance across all comparisons in each network, defined via a generalized methods of moments estimate of the between-studies variance [37].”
MethodGuidelines for the Content of Statistical Analysis Plans in Clinical Trials
Gamble, C., Krishan, A., Stocken, D., Lewis, S., Juszczak, E., Doré, C., Williamson, P. R., Altman, D. G., Montgomery, A., Lim, P., et al. (2017) · JAMA · doi:10.1001/jama.2017.18556 · Cited by 536 · cited 1×
“To ensure their utility in overcoming limitations of the current body of evidence for informing policy and practice, researchers should design future studies that are adequately powered and fit for this pragmatic purpose [53], prospectively register fully developed protocols and statistical analysis plans [54,55], and…”
BackgroundTreatment of Depression in Patients With Alcohol or Other Drug Dependence: A Meta-analysis
Nunes, E. V., & Levin, F. R. (2004) · JAMA · doi:10.1001/jama.291.15.1887 · Cited by 532 · cited 14×
“• EAU : ThesentenceExistingsystematicreviewsandclinicalpracticeguidelinesoften:::isincomplete:Pleaseupdateandcorrect:xisting sy tematic reviews and clini al practice guidelines of en on either AUDs or depressive disorders, despite the prevalence and significance of their co-occurrence.”
BackgroundInfluentialComparative Effectiveness Research: A Report From the Institute of Medicine
Sox, H. C., & Greenfield, S. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-3-200908040-00125 · Cited by 525
A graphical tool for locating inconsistency in network meta-analyses
Krahn, U., Binder, H., & König, J. (2013) · BMC Medical Research Methodology · doi:10.1186/1471-2288-13-35 · Cited by 458 · cited 1×
“We assessed between-study clinical and methodological heterogeneity by examining study characteristics, between-study statistical heterogeneity for each pairwise comparison using the I(2) statistic, local inconsistency by splitting and comparing direct and indirect evidence [38], and global inconsistency using designb…”
MethodFluoxetine in Depressed Alcoholics: A Double-blind, Placebo-Controlled Trial
Cornelius, J. R. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830200024004 · Cited by 357
Antidepressants versus placebo for depression in primary care
Arroll, B., Elley, C. R., Fishman, T., Goodyear-Smith, F. A., Kenealy, T., Blashki, G., Kerse, N., & MacGillivray, S. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007954 · Cited by 352
O. B. O. T. C.-S. G., Grant, S., Mayo-Wilson, E., Montgomery, P., Macdonald, G., Michie, S., Hopewell, S., & Moher, D. (2018) · Trials · doi:10.1186/s13063-018-2735-z · Cited by 348
Self-citationUnderstanding controlled trials: What is a patient preference trial?
Torgerson, D., & Sibbald, B. (1998) · BMJ · doi:10.1136/bmj.316.7128.360 · Cited by 304
Welch, V., Petticrew, M., Petkovic, J., Moher, D., Waters, E., White, H., Tugwell, P., Atun, R., Awasthi, S., Barbour, V., et al. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.09.001 · Cited by 297
RAISTRICK, D., BRADSHAW, J., TOBER, G., WEINER, J., ALLISON, J., & HEALEY, C. (1994) · Addiction · doi:10.1111/j.1360-0443.1994.tb03332.x · Cited by 293
Levels of anxiety and depression as predictors of mortality: the HUNT study
Mykletun, A., Bjerkeset, O., øverland, S., Prince, M., Dewey, M., & Stewart, R. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.054866 · Cited by 279
(2016) · doi:10.1002/14651858.cd201601 · Cited by 278
Riper, H., Andersson, G., Hunter, S. B., Wit, J., Berking, M., & Cuijpers, P. (2014) · Addiction · doi:10.1111/add.12441 · Cited by 276
Rücker, G., & Schwarzer, G. (2014) · Statistics in Medicine · doi:10.1002/sim.6236 · Cited by 217 · cited 1×
“We addressed within-study correlation of effects from multiarm trials through the netmeta procedures for reweighting all comparisons of each multiarm trial [35,36].”
MethodImipramine Treatment of Alcoholics With Primary Depression: A Placebo-Controlled Clinical Trial
McGrath, P. J. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830030054009 · Cited by 212
Takahashi, A. (1998) · International Clinical Psychopharmacology · doi:10.1097/00004850-199801000-00048 · Cited by 183
Baker, A., Thornton, L. K., Hiles, S. A., Hides, L. M., & Lubman, D. I. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.004 · Cited by 175
Agyapong, V. I. O., Ahern, S., McLoughlin, D. M., & Farren, C. K. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.02.040 · Cited by 165
Foulds, J., Adamson, S. J., Boden, J. M., Williman, J. A., & Mulder, R. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.06.024 · Cited by 155 · cited 1×
“Previous reviews have found antidepressants to be more effective than placebo in treating depression among patients with comorbid AUDs [14,22], as well as finding clinical intervention in general (any form of medication or psychosocial treatment) for depression co-occurring with an AUD to be associated with an early i…”
BackgroundUnderstanding controlled trials: What is Zelen's design?
Torgerson, D. J., & Roland, M. (1998) · BMJ · doi:10.1136/bmj.316.7131.606 · Cited by 141
Antidepressants for the treatment of people with co-occurring depression and alcohol dependence
Agabio, R., Trogu, E., & Pani, P. P. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008581.pub2 · Cited by 131 · cited 1×
“, remission from depression and depressive symptoms), and the risk of developing adverse effects appeared to be minimal [49].”
BackgroundMuhonen, L. H., Lonnqvist, J., Juva, K., & Alho, H. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0308 · Cited by 118
the PRISMA-Equity Bellagio group, Welch, V., Petticrew, M., Petkovic, J., Moher, D., Waters, E., White, H., & Tugwell, P. (2015) · International Journal for Equity in Health · doi:10.1186/s12939-015-0219-2 · Cited by 114 · cited 2×
“We collected participant data based on the PRISMA-Equity Extension [25,26], intervention and comparator data using the template for intervention description and replication [27], outcome data using ClinicalTrials.gov criteria for completed defined outcomes [28], study setting data using the Consolidated Framework for…”
MethodMoak, D. H., Anton, R. F., Latham, P. K., Voronin, K. E., Waid, R. L., & Durazo-Arvizu, R. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000095346.32154.41 · Cited by 112
Harms are assessed inconsistently and reported inadequately Part 2: nonsystematic adverse events
Mayo-Wilson, E., Fusco, N., Li, T., Hong, H., Canner, J. K., Dickersin, K., Bertizzolo, L., Cowley, T., Doshi, P., Ehmsen, J., et al. (2019) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.04.020 · Cited by 109 · cited 1×
“Given concerns about use of some pharmacological interventions in patients with AUDs (due to potential interactions with medications and alcohol), this research area would also benefit from standards on the collection and reporting of adverse events [58].”
BackgroundPetersen, C. L., & Zettle, R. D. (2009) · The Psychological Record · doi:10.1007/bf03395679 · Cited by 108
Klimas, J., Tobin, H., Field, C.-A., O'Gorman, C. S., Glynn, L. G., Keenan, E., Saunders, J., Bury, G., Dunne, C., & Cullen, W. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009269.pub3 · Cited by 106 · cited 25×
“Studies had to include adult participants (at least 50% were 18 years of age or older) with clinical diagnoses for both an AUD and depressive disorder according to Diagnostic and Statistical Manual of Mental Disorders (DSM) or International Classification of Diseases (ICD) criteria.”
BackgroundInfluentialHobbs, J. D. J., Kushner, M. G., Lee, S. S., Reardon, S. M., & Maurer, E. W. (2011) · The American Journal on Addictions · doi:10.1111/j.1521-0391.2011.00140.x · Cited by 104
Sertraline Treatment of Co-occurring Alcohol Dependence and Major Depression
Kranzler, H. R., Mueller, T., Cornelius, J., Pettinati, H. M., Moak, D., Martin, P. R., Anthenelli, R., Brower, K. J., O'Malley, S., Mason, B. J., et al. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000194620.61868.35 · Cited by 99
Placebo-controlled study of sertraline in depressed recently abstinent alcoholics
Roy, A. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00509-x · Cited by 86
'Third wave' cognitive and behavioural therapies versus treatment as usual for depression
Churchill, R., Moore, T. H., Furukawa, T. A., Caldwell, D. M., Davies, P., Jones, H., Shinohara, K., Imai, H., Lewis, G., & Hunot, V. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008705.pub2 · Cited by 82
Iovieno, N., Tedeschini, E., Bentley, K. H., Evins, A. E., & Papakostas, G. I. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06217 · Cited by 80 · cited 15×
“• EAU : ThesentenceExistingsystematicreviewsandclinicalpracticeguidelinesoften:::isincomplete:Pleaseupdateandcorrect:xisting sy tematic reviews and clini al practice guidelines of en on either AUDs or depressive disorders, despite the prevalence and significance of their co-occurrence.”
BackgroundInfluentialTreatment of Late-Life Depression Complicated by Alcohol Dependence
Oslin, D. W. (2005) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200506000-00008 · Cited by 80
Roy-Byrne, P. P., Pages, K. P., Russo, J. E., Jaffe, C., Blume, A. W., Kingsley, E., Cowley, D. S., & Ries, R. K. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200004000-00003 · Cited by 74
Markowitz, J. C., Kocsis, J. H., Christos, P., Bleiberg, K., & Carlin, A. (2008) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0b013e31817738f1 · Cited by 71
Defining certainty of net benefit: a GRADE concept paper
Alper, B. S., Oettgen, P., Kunnamo, I., Iorio, A., Ansari, M. T., Murad, M. H., Meerpohl, J. J., Qaseem, A., Hultcrantz, M., Schünemann, H. J., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027445 · Cited by 68 · cited 1×
“, the balance between desirable and undesirable health effects) [51] across interventions in systematic reviews [52].”
BackgroundHarms are assessed inconsistently and reported inadequately part 1: systematic adverse events
Mayo-Wilson, E., Fusco, N., Li, T., Hong, H., Canner, J. K., Dickersin, K., Bertizzolo, L., Cowley, T., Doshi, P., Ehmsen, J., et al. (2019) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.04.022 · Cited by 63 · cited 1×
“, the balance between desirable and undesirable health effects) [51] across interventions in systematic reviews [52].”
BackgroundTreatment of the Depressed Alcoholic Patient
DeVido, J. J., & Weiss, R. D. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0314-7 · Cited by 61 · cited 2×
“Cooccurring AUD and depression results in worse treatment outcomes on average compared with patients diagnosed with only one of these disorders [6].”
BackgroundTreatment of depression in alcoholics
Shaw, J. A., Donley, P., Morgan, D. W., & Robinson, J. A. (1975) · American Journal of Psychiatry · doi:10.1176/ajp.132.6.641 · Cited by 58
Node-making process in network meta-analysis of nonpharmacological treatment are poorly reported
James, A., Yavchitz, A., Ravaud, P., & Boutron, I. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.11.018 · Cited by 58 · cited 1×
“After completing the search but before extracting and analyzing outcome data, we assigned identified interventions to nodes in our network via consensus among the review team and external advisers, using a preregistered list of intervention nodes (see S1 Text) as a guide [24].”
MethodAdamson, S. J., Sellman, J. D., Foulds, J. A., Frampton, C. M. A., Deering, D., Dunn, A., Berks, J., Nixon, L., & Cape, G. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000287 · Cited by 51
The Seven C's of CBT: A Consideration of the Future Challenges for Cognitive Behaviour Therapy
Mansell, W. (2008) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465808004700 · Cited by 48
Altintoprak, A. E., Zorlu, N., Coskunol, H., Akdeniz, F., & Kitapcioglu, G. (2008) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.935 · Cited by 40
Network Meta-Analysis using Frequentist Methods [R package netmeta version 1.3-0]
Rücker, G., Krahn, U., König, J., Efthimiou, O., Davies, A. L., Papakonstantinou, T., & Schwarzer, G. (2021) · Cited by 40
Han, D. H., Kim, S. M., Choi, J. E., Min, K. J., & Renshaw, P. F. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881112472563 · Cited by 39
Alcoholism and depression: a placebo controlled study with viloxazine.
Altamura, A. C., Mauri, M. C., Girardi, T., & Panetta, B. (1990) · PubMed · Cited by 35
Klimas, J., Field, C.-A., Cullen, W., O'Gorman, C. S., Glynn, L. G., Keenan, E., Saunders, J., Bury, G., & Dunne, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009269.pub2 · Cited by 31
Depression Associated with Alcohol Withdrawal; Imipramine Therapy Compared with Placebo
Butterworth, A. T. (1971) · Quarterly Journal of Studies on Alcohol · doi:10.15288/qjsa.1971.32.343 · Cited by 27
Hellerstein, D. J., Batchelder, S. T., Lee, A. Y. Y., & Borisovskaya, M. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00371-8 · Cited by 25
Cornelius, J. R., Chung, T. A., Douaihy, A. B., Kirisci, L., Glance, J. B., Kmiec, J. A., FitzGerald, D., Wesesky, M. A., & Salloum, I. M. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.06.005 · Cited by 25
Network Meta-Analysis for Complex Social Interventions: Problems and Potential
Grant, E. S., & Calderbank-Batista, T. (2013) · Journal of the Society for Social Work and Research · doi:10.5243/jsswr.2013.25 · Cited by 24 · cited 2×
“We then qualitatively examined the distribution of characteristics across studies in each network that may modify intervention effects to assess the transitivity assumption of NMA—that is, that participants hypothetically could be randomized to any interventions included in a network [32,33].”
BackgroundHolzhauer, C. G., & Gamble, S. A. (2017) · Psychology of Addictive Behaviors · doi:10.1037/adb0000274 · Cited by 20
Mecamylamine for Treatment of People With Dual Diagnoses of Depression and Alcohol Dependence
Ralevski, E., Jane, J. S., O’Brien, E. M., Edens, E. L., Arnaout, B., Kerfoot, K. E., Keegan, K. A., Weiner, J., Russo, M., & Petrakis, I. L. (2013) · Journal of Dual Diagnosis · doi:10.1080/15504263.2013.835163 · Cited by 6
McLean, P., Ancill, R. J., & Szulecka, T. K. (1986) · PubMed · Cited by 4
Riper, H. M., Andersson, G., Hunter, S. B., de Wit, J., Berking, M., & Cuijpers, P. J. (2014) · Cited by 3
Research works printed but not linked: 1
- JPT Higgins, 2016, Methodological Expectations of Cochrane Intervention Reviews
Cited by
Bahji, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13040999 · Cited by 83
“In fact, some research suggests that combining SSRIs with AUD treatment can yield significant benefits, emphasizing the critical importance of addressing both conditions concurrently [60–62].”
BackgroundNicola, M. D., Pepe, M., Panaccione, I., Moccia, L., Janiri, L., & Sani, G. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230403080624 · Cited by 25
“…meta-analysis further confirmed the abovementioned findings, suggesting that treatment with TCAs and Selective Serotonin Reuptake Inhibitors (SSRIs) improves depressive symptoms and functional status in patients dually diagnosed, while effects on drinking outcomes appeared to be less relevant [17].”
ResultFilippis, S. D., Martinotti, G., Nicoletti, F., Mastrostefano, A., Trovini, G., Pugliese, A., & Nicola, M. D. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666240827165327 · Cited by 23
“For example, treatment with SSRIs and TCAs improved MDD symptoms bur was less effective in reducing AUD-related symptoms [246].”
Concurrent Disorders and Treatment Outcomes: A Meta-Analysis
Scott, K. D., & Gorey, K. M. (2025) · Journal of Dual Diagnosis · doi:10.1080/15504263.2025.2515015 · Cited by 18
“…Coles et al., 2021; DiFerdinando, 2006; Fitzpatrick-Lewis et al., 2011; Flanagan et al., 2016; Garrod et al., 2020; Glover-Wright et al., 2023; Grant et al., 2021; Hakobyan et al., 2020; Holland & Tickle, 2023; Hunt et al., 2013; Ipser et al., 2015; Issa, 2023; Johnson, 2020; Karapareddy,…”
Alcohol use disorder with comorbid anxiety disorder: a case report and focused literature review
Mocanu, V., & Wood, E. (2022) · Addiction Science & Clinical Practice · doi:10.1186/s13722-022-00344-z · Cited by 14
Metadata
- Authors
- Grant, S., Azhar, G., Han, E., Booth, M., Motala, A., Larkin, J., & Hempel, S.
- Affiliations
- RAND Corporation (US)
- Corresponding author
- Grant, Sean
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2021-10-08
- Volume
- 18
- Issue
- 10
- Pages
- e1003822
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC8535380
- OpenAlex
- W3117035996
- Cited by
- 31
- References
- 102
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 7 · 2023: 4 · 2022: 3 · 2021: 1
- FWCI
- 0.57
- Type
- journal article
- Language
- en
- Update notices
- new_version (2021-10-22)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IUScholarWorks (Indiana University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- U.S. Department of Defense (Psychological Health Center of Excellence)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- alcoholism, depressive disorders, comorbidities, dual diagnosis, cognitive behavioral therapy, tricyclic antidepressants, selective serotonin reuptake inhibitors, antidepressant augmentation, adjunctive pharmacotherapy, psychological intervention, depression remission, health-related quality of life, functional status, adverse events, treatment effectiveness comparison, adults, treatment-resistant depression, heavy drinking
- MeSH terms
- Adult, Alcoholism, Depression, Female, Humans, Male, Middle Aged, Quality of Life, Remission Induction, Risk, Substance Withdrawal Syndrome, Comorbidity, Publication Bias
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.